Shantou University Medical College, Shantou, China.
Department of General Surgery, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.
Arch Dis Child. 2020 Aug;105(8):720-723. doi: 10.1136/archdischild-2019-317787. Epub 2020 Jun 9.
To elaborate on the implementation and achievements of a biliary atresia (BA) screening programme in Shenzhen.
In 2015, we partnered with the government in Shenzhen and attached the stool colour card (SCC) to the health handbook for mothers and children. These handbooks have been distributed through official channels to every pregnant woman in Shenzhen since 1 January 2015. A total of 118 patients diagnosed with BA at Shenzhen Children's Hospital were enrolled and divided into two cohorts based on their date of diagnosis: cohort A before and cohort B after introduction of screening. The cohorts were compared to evaluate differences in age at diagnosis, jaundice-free rate, 2-year native liver survival rate and so on.
After the implementation of the screening programme, the age at diagnosis decreased from 81±12 to 56±15 days old (p<0.05), the incidence of postoperative complications decreased from 58.8% to 52.6% (p<0.05), the jaundice-free rate increased from 47.1% to 54.4% (p<0.05), and the 2-year native liver survival rate increased from 44.4% to 52.6% (p<0.05). The percentage of patients who underwent surgery increased from 68.0% to 83.8% (p<0.05).
In Shenzhen, our screening programme led to earlier diagnoses and better prognoses. The latter resulted in an increased willingness to undergo the Kasai procedure. Through a hospital and government collaboration, this programme exerted a considerable influence, and guardians observed benefits with only a small cost of implementation. Our results may eventually help promote the widespread use of the SCC across the whole country.
阐述深圳市胆道闭锁(BA)筛查项目的实施情况和成果。
2015 年,我们与深圳市政府合作,在母子健康手册中加入了粪便颜色卡(SCC)。自 2015 年 1 月 1 日起,通过官方渠道向深圳市的每位孕妇发放这些手册。共纳入 118 例在深圳市儿童医院诊断为 BA 的患者,根据诊断日期分为 A 队列(筛查前)和 B 队列(筛查后)。比较两组在诊断年龄、无黄疸率、2 年肝存活率等方面的差异。
实施筛查项目后,诊断年龄从 81±12 天降至 56±15 天(p<0.05),术后并发症发生率从 58.8%降至 52.6%(p<0.05),无黄疸率从 47.1%提高到 54.4%(p<0.05),2 年肝存活率从 44.4%提高到 52.6%(p<0.05)。手术患者比例从 68.0%提高到 83.8%(p<0.05)。
在深圳市,我们的筛查项目使诊断更早,预后更好。这导致更多的患者愿意接受 Kasai 手术。通过医院和政府的合作,该项目产生了相当大的影响,监护人在实施成本很小的情况下观察到了好处。我们的结果最终可能有助于促进 SCC 在全国范围内的广泛应用。